Goran Babić

Risk factors for potential drug-drug interactions in intensive care unit patients

Ana V. Pejčić, Miloš N. Milosavljević, Valentina Opančina et al. · Journal of Critical Care · 2017 · 72 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Efficacy, safety and immunogenicity of GP2015, an etanercept biosimilar, compared with the reference etanercept in patients with moderate-to-severe rheumatoid arthritis: 24-week results from the comparative phase III, randomised, double-blind EQUIRA study

Marco Matucci‐Cerinic, Yannick Allanore, Arthur Kavanaugh et al. · RMD Open · 2018 · 41 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Switch from reference etanercept to SDZ ETN, an etanercept biosimilar, does not impact efficacy, safety, and immunogenicity of etanercept in patients with moderate-to-severe rheumatoid arthritis: 48-week results from the phase III, randomized, double-blind EQUIRA study

Janusz Jaworski, Marco Matucci‐Cerinic, Hendrik Schulze‐Koops et al. · Arthritis Research & Therapy · 2019 · 33 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from week 30 to week 54

Rieke Alten, Bogdan Batko, Tomas Hala et al. · RMD Open · 2019 · 26 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Panic Disorder as Unthinkable Emotions: Alexithymia in Panic Disorder, a Croatian Cross-Sectional Study

Daniela Šago, Goran Babić, Žarko Bajić et al. · Frontiers in Psychiatry · 2020 · 17 citations · Full text

Social Sciences, Psychiatry, Psychology +15